Third leading cause of cancer mortality in the US.
Uncommon in men aged under 50 years.
PSA and digital rectal examination are key diagnostic tools used in screening.
Management may be expectant or definitive.
The overall 5-year relative survival rate for 2002 to 2008 was 96% to 100%, but this varies greatly depending on the National Comprehensive Cancer Network (NCCN) risk category.